chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a certified medical assistant referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown dates, the patients were vaccinated with an improperly store dose of ROTATEQ lot # L033548 and expiration date of 05-MAY-2017 oral for prophylaxis (dose and route of administration were not reported) reconstituted with properly stored sterile diluent. It could not be confirmed whether or not any doses of improperly stored of ROTATEQ were administered past the expiration date. No symptoms were reported. The vaccine was exposed to a temperature excursion of 47.5°F with a time frame of 30 minutes. There was no previous temperature excursion. A "data logger" was involved. Sender's Comments: US-009507513-1709USA004156.
On June 7, 2022 I started feeling lethargic I had a fever of 101.8F, then chills. My fever broke around 10:00am June 8, 2022 when I tested positive for COVID-19. I developed a cough that was more in my left side than my right. I did not lose my taste or smell but everything seemed to tasty excessive. I felt like I had ran a marathon and body needed quick carbs, I was craving sweets, waffles with maple syrup. After ten days I went to the clinic to get treated for the persistent cough. I tested negative after fourteen days.
Have Had covid and second dose is coming; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Have Had covid and second dose is coming) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Have Had covid and second dose is coming). At the time of the report, COVID-19 (Have Had covid and second dose is coming) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment medication was not reported.  second dose was schedules on 27 May 2021.
This case was reported by a other health professional via call center representative and described the occurrence of muscle soreness in a female patient who received Flu unspecified (Flu vaccine) for prophylaxis. The patient's past medical history included genital herpes (since 1980). On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced muscle soreness. On an unknown date, the outcome of the muscle soreness was recovered/resolved. It was unknown if the reporter considered the muscle soreness to be related to Flu vaccine. Additional details were reported as follows: This case was not previously reported to the physician. The patient received Flu vaccine in unknown arm. The patient had muscle soreness in the same arm in which the patient received vaccine. The patient stated that the muscle soreness usually starts that same evening or the next day following the vaccine and usually subsides after a couple of days. The patient had limited information regarding the flu vaccine. Patient did want to provide her DOB and provided her age instead. This case was link to case US2018160791, reported by the same reporter for the same patient.
involuntary twitching in different parts of the body/twitching primarily area was in the throat towards left side; had diarrhea; tinnitus (actually had it before); bloody nose; dizziness; joint pain; experience fatigue; soreness of the arm for couple day/soreness continue but was minor; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (involuntary twitching in different parts of the body/twitching primarily area was in the throat towards left side), DIARRHOEA (had diarrhea), TINNITUS (tinnitus (actually had it before)), EPISTAXIS (bloody nose) and DIZZINESS (dizziness) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Tinnitus (had it before). Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ), IBUPROFEN (MOTRIN IB), VITAMIN C [ASCORBIC ACID] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (involuntary twitching in different parts of the body/twitching primarily area was in the throat towards left side), DIARRHOEA (had diarrhea), TINNITUS (tinnitus (actually had it before)), EPISTAXIS (bloody nose), DIZZINESS (dizziness), ARTHRALGIA (joint pain), FATIGUE (experience fatigue) and MYALGIA (soreness of the arm for couple day/soreness continue but was minor). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MUSCLE TWITCHING (involuntary twitching in different parts of the body/twitching primarily area was in the throat towards left side), DIARRHOEA (had diarrhea), TINNITUS (tinnitus (actually had it before)), EPISTAXIS (bloody nose), DIZZINESS (dizziness), ARTHRALGIA (joint pain), FATIGUE (experience fatigue) and MYALGIA (soreness of the arm for couple day/soreness continue but was minor) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal (normal) normal. On an unknown date, Sinus rhythm: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient went to Urgent Care to get fully checked on the side effect especially on the twitching and patient stated they took Claritin after 1st week but it was more for allergies but afterward it was fine. Other concomitant medications include Vitamin gummies and Claritin.   This case was linked to MOD-2021-362000 (Patient Link).
This spontaneous report as received from a medical assistant refers to an approximately 13 years old female patient with no pertinent medical history or drug allergy. The patient was vaccinated with the first dose of VARIVAX (Merck) on 22-DEC-1999. No other co-suspects were reported. No concomitant medications were reported. On an unknown date after the vaccination of VARIVAX (Merck) the patient developed chickenpox. The patient's mother called office where the medical assistant worked for medical attention. The reporter stated that the patient was never administered the second dose of VARIVAX (Merck). The outcome of chickenpox was reported as recovered/resolved on an unknown date. Additional information is not expected.
I had been doing the vsafe check-ins and it came in yesterday and it was the same day I went to the doctor for my annual exam. when they tested my glucose it was extremely high which it had never been before. I wasn't displaying symptoms but it was caught because of my annual report.
Redness and swelling at injection site. Augmentin 250mg 1 1/2 tsp Bio x 10 days
?Pfizer-BioNTech COVID-19 Vaccine EUA?  Vaccine administration error related to temperature excursion from recommended storage temperature, not known to this writer to be associated with an adverse event. The clinic has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer. (This VAERS writer assigned to form completion was not the administrator of this vaccine.)   Outcome: As of today's VAERS report, vaccine recipient attempted to be reached x 3, letter mailed to home address by staff.
Pt received varicella vaccine RA SQ on 2-4-09 and returned to office 2-16-09 with red/swollen (15 mm) in area around injection site and reported area itches instructions given per VIS and to return if area worsens or gets larger.
Patient received full dose of Moderna and was supposed to receive the booster dose. Medical Assistant pulled out the full dose from a basket in the cooler and did not verify the dose as a full dose instead of booster. Patient contacted and denied any side affects at the time of the call.
Patient was incorrectly adminsitered the MMR vaccine following vaginal delivery of newborn. Vaccine was intended for a different patient. Patient tolerated the dose and had been vaccinated previously. No adverse effects. Patient and provider were notified of error and educated on adverse effects to monitor for.  Pt was provided VIS sheet for vaccine. Pt was discharged in stable condition.
I had a sore arm for roughly two days after the shot which isn?t a biggie.  But the day after I got it I experienced a high fever and vomiting which has continued and this is the 3rd after the vaccine. I?ve been incapacitated due to the nausea. It?s the worst in the morning and gets some what better throughout the day.
a bad case of the shingles; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On or around 10-OCT-2014, the patient was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiry date were not provided) for routine health maintenance and for the prevention of shingles (herpes zoster). On an unknown date (reported as shortly after the vaccination), the patient suffered a bad case of the shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). She also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. The patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX) vaccination, she suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of shingles was reported as not recovered. The event of shingles was considered to be related to zoster vaccine live (ZOSTAVAX).  The event of shingles was considered to be disabling.
Patient called on 6/18/2021 to report  a case of Bell's palsy after receiving Moderna vaccine shot on 4/24/2021.He said he has numbness, pain and weakness in the left side of his face, lips, upper teeth  and eye pain. He started documenting symptoms on 5/10/2021 and his provider knows about that .He does not remember when he started experiencing side effects. He had appointment with his eye care professional who sent him to PCP to evaluate signs similar to stroke. After visiting his doctor ,he was diagnosed with Bell's palsy.
administered expired doses; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number 7YA99, expiry date 30th September 2022) for prophylaxis.   On 4th October 2022, the patient received Havrix. On 4th October 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.      Additional Information: GSK Receipt Date: 18-OCT-2022 Reporter's comment: Medical assistance reported that a patient was administered expired dose of Havrix on different date. The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow-up. Additional Supportive Information: The patient received a dose of Havrix which was already expired, which led to expired vaccine used. This case was one of the 4 cases reported by the same reporter.; Sender's Comments:  US-GSK-US2022149860:Same reporter US-GSK-US2022149858:Same reporter US-GSK-US2022149859:Same reporter
a little sore on site on the first day; This is a spontaneous report from a contactable nurse (patient). An 81-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EH9899, expiry date: 31Mar2021), via an unspecified route of administration on 21Dec2020 at a single dose for covid-19 immunization. Medical history included colitis, diverticulitis and allergies. Concomitant medications included chlordiazepoxide hydrochloride, clidinium bromide (LIBRAX [CHLORDIAZEPOXIDE HYDROCHLORIDE;CLIDINIUM BROMIDE]) for colitis, omeprazole (PROTONIX [OMEPRAZOLE]), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for allergies, and cyanocobalamin, folic acid (VITAMIN B12 & FOLIC ACID) for colitis. The patient experienced a little sore on site on the first day on 21Dec2020. Outcome of the event was recovered on 22Dec2020.
My idiopathic iritis has been flaring up non-stop since my shot.; My idiopathic iritis has been flaring up non-stop since my shot.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 14:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included idiopathic iritis and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included full spectrum cannabidiol (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 07:00 the idiopathic iritis had been flaring up non-stop since his shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of idiopathic iritis and included treatment with Durezol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event idiopathic iritis was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
expired vaccine administered; no adverse effect reported; This spontaneous report as received from a Nurse refers to a  second patient of an unknown age and unknown gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 13-MAY-2019, the second patient received a dose with rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (Lot number N030364 and expiry date 06-MAR-2019), route via oral for an unknown indication. The nurse reported that, the patient received expired rotavirus vaccine, live, oral, pentavalent(ROTATEQ)(expired product administered). No adverse effect was reported(No adverse event).
No adverse effects reported.; received unspecified dose of Varivax series that was improperly stored; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. On 25-JUN-2019, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # S003448, expiration date 04-FEB-2021) for prophylaxis (exact dose, frequency, route of administration was not reported). The patient's concomitant therapies included properly stored sterile diluent. The dose of vaccine experienced a temperature excursion of 12.4 degrees Fahrenheit for 16 minutes. No previous temperature excursion was reported. Data logger was involved in recording the excursion details. No adverse event was reported.
No adverse effect reported.; the patient was inadvertently administered a dose of GARDASIL 9; This spontaneous report has been received from a registered nurse concerning a patient of unknown age and gender.   On 08-OCT-2019, the patient was inadvertently vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) which had been improperly stored, with lot # S005524 and expiration date on 29-SEP-2021; administered for prophylaxis (dose, dose number, route of administration and anatomical location were not provided).  It was reported that on an unspecified date, the vaccine was exposed to a temperature of -6 degree Celsius for 14 hours. There was no previous temperature excursion. The call was not placed because of a Digital Data logger report. No adverse effects were reported.
On 3/29/21 patient developed palpitations that have been occurring intermittently through the day.
This spontaneous case was reported by a patient family member or friend and describes the occurrence of ILLNESS (Caller's brother has been sick) in a male patient of an unknown age who received mRNA-1273  for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273  (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS . At the time of the report, ILLNESS outcome was unknown.        The action taken with mRNA-1273 (Unknown) was unknown.       No concomitant medications were reported.  Patient had been sick for constantly 5 day.  No treatment medications were reported.
fever 105 & febrile seizure;this child is an international adoptee w/no records of prev immun;physical age doesn't correspond to birthdate on papers;child appears younger than 4 years;
Brain fog, confusion, heart palpitations, hot flashes, jittery muscles, weakness in arm opposite of injection site, numbness in lips, flashes of light in peripheral vision, slight chest pain, wobbly gait, difficulty remaining conscious.
Patient complaint of lightheaded. Patient passed out after receiving the vaccine. Patient jerked for 2 seconds. Patient was pale. Client regained consciousness after 4-5 seconds . Lowered on the ground, legs elevated. vitals checked, ice pack applied., and water provided. Patient color regained . 45 observation. Patient left the site with  steady gait with his partner
Patient presented to hospital 3 days after vaccine with severe headache, leg pain, nausea, subjective fever and chills.
pt seen 21JUN97 by MD;mom relates pt broke out in rash 9th day p/vax dx as German measles;rash improving but @ inj site nickel size red, abrasion like area;
1/27/2023   I thought I had a cold, which I don?t normally get. During the night, my nose was runny. The next day I did an at home COVID test and it was positive. I had a telehealth visit with the nurse.  I was prescribed Paxlovid which I started taking that night, 1/28/23.  It seemed to help,I got over it really quickly. I took the Paxlovid for 5 days.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid test positive"; EXPOSURE TO SARS-COV-2 (medically significant), outcome "unknown", described as "often near people who test positive for Covid". The patient was often near people who test positive for COVID and were likely vaccinated. It was a frequent occurrence. Two roommates have at one point or another tested positive. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive..  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101858695 same reporter/vaccine, different patients, similar events
Expired vaccine administered to a patient.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to a patient.) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A, 010A21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to a patient.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to a patient.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The vial did not undergo any temperature excursions. The patient did not experience any other adverse reactions. The nurse said that when the lot number of Moderna Covid-19 vaccine of 010A21A was entered into the expiration date lot number look up finder on Moderna website the expiration date was 14-Aug-2021. The nurse said that she had a screenshot of the above lot number 010A21A entered into the lot number expiration date check program that shows the expiration date as 14-Oct-2022. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Mar-2022: Significant live follow up (Quality complaint number updated) On 11-Mar-2022: Follow up document includes reporter information was added.
Initial report was received from a consumer, who was also the patient, on 11 October 2012. A 30-year-old female patient received an injection of INFLUENZA VACCINE, manufacturer unknown (lot number, route, site, side and dose in series not reported) on 03 October 2012. On 05 October 2012, two days post vaccination she reported adverse event onset. On 07 October 2012, four days after vaccination, the patient went to the emergency room (ER) and was told she "had a panic attack", was given XANAX and sent home. On 08 October 2012, five days after vaccination, she went back to the ER because she "could not breathe". She was told it was a "panic attack and heart rate and blood pressure (BP) went up". X-rays (site unspecified) and electrocardiogram (EKG) were all negative. On 10 October 2012, she went to the doctor office to tell him what happened. Her doctor said it was not anxiety and had to do with her heart and he told her to come back for more EKGs. The patient reported she used her boyfriend's nebulizer treatment on unspecified date. The patient had a medical history of hypertension (HTN), hypercholesterol, vitamin deficiency and an ulcer. The report stated no known allergies, other than a "pain killer" (not specified). She denied any illness at time of vaccination. The patient's outcome was not reported. Documents held by sender: None.